Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant
1 other identifier
interventional
78
1 country
1
Brief Summary
The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are: Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation? Participants performed: Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
September 20, 2024
CompletedSeptember 20, 2024
September 1, 2024
2 years
September 16, 2024
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Respiratory Muscle Stregnth Test
Respiratory muscle strength was determined by Maximum Inspiratory Pressure (MIP) using a pressure monometer.
Throughout the study completion, approximately 3 month
Secondary Outcomes (3)
Oxygenation status
Participants underwent maximum inspiratory and expiratory pressure measurements at four time points: upon admission, before discharge from the intensive care unit, before discharge from the hospital, and at the end of the 12-week enrollment period.
Dyspnea Severity Assessment
Throughout the study completion, approximately 3 month
Forced Vital Capacity
Throughout the study completion, approximately 3 month
Study Arms (2)
Inspiratory Muscle Training group
EXPERIMENTALParticipants received a 12-week inspiratory muscle training and incentive spirometry therapy after discharged from hospital
Routine care
SHAM COMPARATORParticipants received incentive spirometry therapy only
Interventions
Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.
Participants received routine care, which included encouragement to use incentive spirometry three times daily.
Eligibility Criteria
You may qualify if:
- Age 20 years or older
- Scheduled to undergo living donor liver transplantation
- Stable vital signs
- Normal cognitive function
- Able to perform activities independently using their own strength and coordination
- Willing and able to participate in 12 weeks of rehabilitation training
You may not qualify if:
- Severe physical illness during the operation
- Acute bleeding
- Unstable vital signs
- Hepatic encephalopathy, or neurological conditions such as stroke, Parkinson\'s disease, or cognitive dysfunction
- Limited mobility (e.g., unable to stand, lift upper limbs, or bedridden)
- Inability to comply with 12 weeks of pulmonary rehabilitation post-discharge
- Unstable vital signs
- Hepatoencephalopathy, such as cardiovascular accident, Parkinson disease, cognitive dysfunction
- Those with limited mobility (unable to stand, unable to lift upper limbs, or bedridden)
- Those who are unable to cooperate with the 12 weeks of pulmonary rehabilitation exercises after discharge.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chang Gung Universitylead
- Chang Gung University of Science and Technologycollaborator
- Chang Gung Memorial Hospitalcollaborator
Study Sites (1)
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Related Publications (2)
Au KP, Chan SC, Chok KS, Sharr WW, Dai WC, Sin SL, Wong TC, Lo CM. Clinical factors affecting rejection rates in liver transplantation. Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):367-73. doi: 10.1016/s1499-3872(15)60391-5.
PMID: 26256080BACKGROUNDAamir,T., Iftikhar,S., Khan, R.R., &Khan, M.K (2019).Role of physiotherapy in improving quality Of life in liver transpant patients. The Rehabilitation Journal, 3(2),126-130.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jui-Fang Lin, PhD
Chang Gung University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 16, 2024
First Posted
September 20, 2024
Study Start
January 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
September 20, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The data will become available 3 three years after the study is completed.
- Access Criteria
- The data is available upon request from the principal investigator.
The data is available upon request from the principal investigator.